ChemicalBook >> CAS DataBase List >>M-443

M-443

CAS No.
1820684-31-8
Chemical Name:
M-443
Synonyms
M-443;M-443 (M443;M443, 10 mM in DMSO;Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-[1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-2-pyrimidinyl]amino]-
CBNumber:
CB54668159
Molecular Formula:
C31H30F3N7O2
Molecular Weight:
589.61
MDL Number:
MFCD31692382
MOL File:
1820684-31-8.mol
Last updated:2025-04-18 09:51:09

M-443 Properties

Density 1.34±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO : 55 mg/mL (93.28 mM)
form Solid
pka 12.95±0.70(Predicted)
color Light yellow to yellow

M-443 Chemical Properties,Uses,Production

Description

M443 is a specific small molecule inhibitor of MRK. M443 strongly radiosensitizes UW228 medulloblastoma cells as well as UI226 patient-derived primary cells, whereas it does not affect the response to radiation of normal brain cells. M443 also inhibits radiation-induced activation of both p38 and Chk2, two proteins that act downstream of MRK and are involved in DNA damage-induced cell-cycle arrest.

Uses

M443 is an irreversible and specific inhibitor of MRK, with an IC50<125 nM.

in vivo

Control mice survive with a median of 32 days after tumor cell implantation. Treatment with M443 alone adds 5.5 days to this survival, whereas the chosen low dose of radiation does not significantly increase survival. In contrast, the combination of M443 and IR extend survival with a median of 16 days longer than control. Treatment with M443 does not affect the animal weight, as the weight loss observed is observed in all groups just a few days before the animals became moribund. It is showed that the tumor-containing fraction has elevated levels of both total and active MRK (lane RB in the vehicle-treated brain). In contrast, the tumor-containing fraction from the M443-treated brain shows total loss of MRK activity. Interestingly, the fractions containing normal brain, which in the control brain show some level of MRK protein, in the treated brain also has lost MRK, suggesting that diffusion of M443 across the whole cerebellum inhibit normal MRK as well[1].

References

[1] Markowitz D, et al. Pharmacological Inhibition of the Protein Kinase MRK/ZAK Radiosensitizes Medulloblastoma. Mol Cancer Ther. 2016 Aug;15(8):1799-808. DOI:10.1158/1535-7163.MCT-15-0849

M-443 Preparation Products And Raw materials

Raw materials

Preparation Products

M-443 Suppliers

Global( 12)Suppliers
Supplier Tel Email Country ProdList Advantage
TargetMol Chemicals Inc.
+1-781-999-5354 +1-00000000000 marketing@targetmol.com United States 32202 58
HANGZHOU CLAP TECHNOLOGY CO.,LTD
86-571-88216897,88216896 13588875226 sales@hzclap.com CHINA 6312 58
ChemeGen(Shanghai) Biotechnology Co.,Ltd. 18818260767 sales@chemegen.com China 11218 58
Shanghai hongqu biomedical technology co. LTD 88888888888 hongquchem@qq.com China 5132 58
cjbscvictory 13348960310 13348960310 3003867561@qq.com China 10523 58
TargetMol Chemicals Inc. 4008200310 marketing@tsbiochem.com China 24683 58
Shanghai Yifei Biotechnology Co. , Ltd. 021-65675885 18964387627 customer_service@efebio.com China 11973 58
Sangon Biotech (Shanghai) Co.,Ltd. 400-821-026 Sales@sangon.com China 47255 58
Biosynth Biological Technology (Suzhou) Co Ltd 51288865780 sales@biosynth.com China 233051 58
Adooq Bioscience LLC 400-025-6535 sales@adooq.cn China 18215 58

View Lastest Price from M-443 manufacturers

Image Update time Product Price Min. Order Purity Supply Ability Manufacturer
M443 pictures 2024-10-24 M443
1820684-31-8
US $199.00 / mg 98.95% 10g TargetMol Chemicals Inc.
  • M443 pictures
  • M443
    1820684-31-8
  • US $199.00 / mg
  • 98.95%
  • TargetMol Chemicals Inc.
M-443 M-443 (M443 Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-[1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-2-pyrimidinyl]amino]- M443, 10 mM in DMSO 1820684-31-8 C31H30F3N7O2